146 related articles for article (PubMed ID: 35931563)
1. Human colonic catabolism of dietary flavan-3-ol bioactives.
Di Pede G; Mena P; Bresciani L; Almutairi TM; Del Rio D; Clifford MN; Crozier A
Mol Aspects Med; 2023 Feb; 89():101107. PubMed ID: 35931563
[TBL] [Abstract][Full Text] [Related]
2. Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols.
Clifford MN; van der Hooft JJ; Crozier A
Am J Clin Nutr; 2013 Dec; 98(6 Suppl):1619S-1630S. PubMed ID: 24172307
[TBL] [Abstract][Full Text] [Related]
3. Flavan-3-ol-methylxanthine interactions: Modulation of flavan-3-ol bioavailability in volunteers with a functional colon and an ileostomy.
Ottaviani JI; Fong RY; Borges G; Kimball J; Ensunsa JL; Medici V; Pourshahidi LK; Kane E; Ward K; Durkan R; Dobani S; Lawther R; O'Connor G; Gill CIR; Schroeter H; Crozier A
Free Radic Biol Med; 2023 Feb; 196():1-8. PubMed ID: 36621554
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation and processing on absorption and metabolism of flavan-3-ols from tea and cocoa.
Neilson AP; Ferruzzi MG
Annu Rev Food Sci Technol; 2011; 2():125-51. PubMed ID: 22129378
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Faecal Fermentation of Monomeric and Oligomeric Flavan-3-ols: Catabolic Pathways and Stoichiometry.
Di Pede G; Bresciani L; Brighenti F; Clifford MN; Crozier A; Del Rio D; Mena P
Mol Nutr Food Res; 2022 Nov; 66(21):e2101090. PubMed ID: 35107868
[TBL] [Abstract][Full Text] [Related]
6. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites.
Monagas M; Urpi-Sarda M; Sánchez-Patán F; Llorach R; Garrido I; Gómez-Cordovés C; Andres-Lacueva C; Bartolomé B
Food Funct; 2010 Dec; 1(3):233-53. PubMed ID: 21776473
[TBL] [Abstract][Full Text] [Related]
7. Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans.
Roowi S; Stalmach A; Mullen W; Lean ME; Edwards CA; Crozier A
J Agric Food Chem; 2010 Jan; 58(2):1296-304. PubMed ID: 20041649
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and catabolism of green tea flavan-3-ols in humans.
Del Rio D; Calani L; Cordero C; Salvatore S; Pellegrini N; Brighenti F
Nutrition; 2010; 26(11-12):1110-6. PubMed ID: 20080030
[TBL] [Abstract][Full Text] [Related]
9. Inter-individual variability in the production of flavan-3-ol colonic metabolites: preliminary elucidation of urinary metabotypes.
Mena P; Ludwig IA; Tomatis VB; Acharjee A; Calani L; Rosi A; Brighenti F; Ray S; Griffin JL; Bluck LJ; Del Rio D
Eur J Nutr; 2019 Jun; 58(4):1529-1543. PubMed ID: 29616322
[TBL] [Abstract][Full Text] [Related]
10. Phenyl-γ-valerolactones and phenylvaleric acids, the main colonic metabolites of flavan-3-ols: synthesis, analysis, bioavailability, and bioactivity.
Mena P; Bresciani L; Brindani N; Ludwig IA; Pereira-Caro G; Angelino D; Llorach R; Calani L; Brighenti F; Clifford MN; Gill CIR; Crozier A; Curti C; Del Rio D
Nat Prod Rep; 2019 May; 36(5):714-752. PubMed ID: 30468210
[TBL] [Abstract][Full Text] [Related]
11. An analysis method for flavan-3-ols using high performance liquid chromatography coupled with a fluorescence detector.
Wang L; Yamashita Y; Saito A; Ashida H
J Food Drug Anal; 2017 Jul; 25(3):478-487. PubMed ID: 28911633
[TBL] [Abstract][Full Text] [Related]
12. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans.
Calani L; Del Rio D; Luisa Callegari M; Morelli L; Brighenti F
Int J Food Sci Nutr; 2012 Aug; 63(5):513-21. PubMed ID: 22133145
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union.
Vogiatzoglou A; Mulligan AA; Luben RN; Lentjes MA; Heiss C; Kelm M; Merx MW; Spencer JP; Schroeter H; Kuhnle GG
Br J Nutr; 2014 Apr; 111(8):1463-73. PubMed ID: 24331295
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic Effects of Flavan-3-ols and Their Microbial Metabolites.
Márquez Campos E; Jakobs L; Simon MC
Nutrients; 2020 May; 12(6):. PubMed ID: 32485837
[TBL] [Abstract][Full Text] [Related]
15. Berry flavonoids and phenolics: bioavailability and evidence of protective effects.
Del Rio D; Borges G; Crozier A
Br J Nutr; 2010 Oct; 104 Suppl 3():S67-90. PubMed ID: 20955651
[TBL] [Abstract][Full Text] [Related]
16. 5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone Is a Substrate for Human Paraoxonase: A Novel Pathway in Flavan-3-ol Metabolism.
Momma TY; Kuhnle GGC; Fong RY; Ensunsa JL; Crozier A; Schroeter H; Ottaviani JI
Mol Nutr Food Res; 2023 Sep; 67(17):e2300281. PubMed ID: 37423968
[TBL] [Abstract][Full Text] [Related]
17. Microbial Metabolites of Flavan-3-Ols and Their Biological Activity.
Márquez Campos E; Stehle P; Simon MC
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31546992
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the bioavailability of flavan-3-ols in humans: A systematic review and comprehensive data analysis.
Di Pede G; Mena P; Bresciani L; Achour M; Lamuela-Raventós RM; Estruch R; Landberg R; Kulling SE; Wishart D; Rodriguez-Mateos A; Crozier A; Manach C; Del Rio D
Mol Aspects Med; 2023 Feb; 89():101146. PubMed ID: 36207170
[TBL] [Abstract][Full Text] [Related]
19. Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts.
Redan BW; Chegeni M; Ferruzzi MG
Food Funct; 2017 Jan; 8(1):111-121. PubMed ID: 27808339
[TBL] [Abstract][Full Text] [Related]
20. In vitro fermentation of grape seed flavan-3-ol fractions by human faecal microbiota: changes in microbial groups and phenolic metabolites.
Cueva C; Sánchez-Patán F; Monagas M; Walton GE; Gibson GR; Martín-Álvarez PJ; Bartolomé B; Moreno-Arribas MV
FEMS Microbiol Ecol; 2013 Mar; 83(3):792-805. PubMed ID: 23121387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
